Agile therapeutics regains compliance with nasdaq minimum bid price requirement

Princeton, n.j., april 26, 2023 (globe newswire) -- agile therapeutics, inc. (nasdaq: agrx), a women's healthcare company, today announced that it has received a notification letter from the listing qualifications department (the “staff”) of the nasdaq stock market (“nasdaq”), informing the company that it has regained compliance with the minimum bid price requirement set forth in nasdaq listing rule 5550(a)(2).
AGRX Ratings Summary
AGRX Quant Ranking